Crinetics Presents Positive Initial Findings for Atumelnant in Congenital Adrenal Hyperplasia and ACTH-Dependent Cushing’s Syndrome

Jun 3, 2024 at 4:30 PM EDT

Crinetics will host an investor conference call on June 3, 2024, at 4:30 pm Eastern Time to discuss the initial findings for atumelnant in two ongoing, open-label studies.

Supporting Materials

Contact


Contact